French hospital hunts for Cancer's weak spots to find right drugs
NCT ID NCT02534649
Summary
This study aims to analyze the genetic makeup of advanced cancers to find specific weaknesses that drugs can target. Researchers will test tumor samples from 10,000 adults with solid tumors or blood cancers. The goal is to use this detailed genetic information to match patients with the most promising experimental or approved treatments in future clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Centre Eugène Marquis
ACTIVE_NOT_RECRUITINGRennes, France
-
Centre Hospitalier de Pau
NOT_YET_RECRUITINGPau, 64000, France
Contact
-
Centre Hospitalier de la Côte Basque
RECRUITINGBayonne, 64000, France
Contact
-
Clinique Marzet
RECRUITINGPau, 64000, France
Contact
-
Clinique Tivoli-Ducos
RECRUITINGBordeaux, 33000, France
Contact Email: •••••@•••••
Contact
-
Institut Bergonie
RECRUITINGBordeaux, 33076, France
Contact
-
Polyclinique Bordeaux Nord Aquitaine
RECRUITINGBordeaux, 33077, France
Contact
Conditions
Explore the condition pages connected to this study.